Ocuphire Pharma
$5.259876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$5.25
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.70 (-11.78%) Today
+$0.01 (+0.19%) As of 10:15 AM UTC after-hours
Why Robinhood?
You can buy or sell OCUP and other stocks, options, and ETFs commission-free!
About OCUP
Ocuphire Pharma, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders.
CEO
Mina Patel Sooch
Employees
5
Headquarters
Farmington Hills, Michigan
Founded
2018
Market Cap
56.50M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
988.79K
High Today
$5.98
Low Today
$5.11
Open Price
$5.85
Volume
1.13M
52 Week High
$14.80
52 Week Low
$3.68
OCUP Earnings
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, After Hours